📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Creative Peptides

1.1 - Company Overview

Creative Peptides Logo

Creative Peptides

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of custom peptide synthesis and process development, specializing in bioactive peptides from small-scale research to large-scale clinical and commercial production. Offers peptide modifications (phosphorylation, glycosylation, lipidation), analysis, pharmaceutical peptide development support (formulation, regulatory compliance), GMP manufacturing for trials and commercial use, and catalog products, including protein glycosylation.

Products and services

  • Peptide Synthesis Services: Custom-engineered synthesis of bioactive peptides ranging from small-scale research peptides to large-scale production for clinical and commercial applications
  • GMP Service: GMP-compliant production of GMP-grade peptides for clinical trials and commercial applications, ensuring adherence to regulatory standards throughout manufacturing
  • Pharmaceutical Peptides Services: Regulatory-focused support for pharmaceutical companies in peptide drug development, formulation, and regulatory compliance, leveraging specialized process development and manufacturing expertise in bioactive peptides

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Creative Peptides

Surepharm Logo

Surepharm

HQ: United Kingdom Website
  • Description: Provider of pharmaceutical contract manufacturing and assembly services for solid dose medicinal and healthcare products, including generic and branded formulations. Offers formulation development; tablet and hard shell capsule manufacturing to GMP; blister packing with child-resistant options; pots/bottles filling; and analytical support, pilot batch management, and stability studies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Surepharm company profile →
ShangPharma Innovation Logo

ShangPharma Innovation

HQ: United States Website
  • Description: Provider of global innovation incubation and investment focused on biomedical R&D technologies and therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ShangPharma Innovation company profile →
Catalyst Clinical Research Logo

Catalyst Clinical Research

HQ: United States Website
  • Description: Provider of clinical operation solutions to biotechnology, pharmaceutical, and medical device companies, built on over two decades of experience supporting clinical development with therapeutically aligned experts and customized solutions. Offers Catalyst Oncology, a full-service CRO for cancer drug development, and Catalyst Flex, FSP services in clinical operations, data management, biostatistics, programming, safety, and medical writing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Catalyst Clinical Research company profile →
3P Biopharmaceuticals Logo

3P Biopharmaceuticals

HQ: Spain Website
  • Description: Provider of biologics and cell therapy development and manufacturing services. Offers comprehensive CDMO support, including process and analytical development, preclinical and clinical supply, and commercial production. Produces proteins via mammalian (CHO, NS0, BHK-21, HEK293, Hybridoma) and microbial (E. coli, P. pastoris, S. cerevisiae, H. pylori, S. noursei) systems, and provides cell therapy technology transfer, process development, cell culture, and GMP certification.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full 3P Biopharmaceuticals company profile →
Eurogentec Logo

Eurogentec

HQ: Belgium Website
  • Description: Provider of GMP biopharmaceutical manufacturing and life science solutions for research, diagnostic and pharmaceutical markets, including large-scale production of plasmid DNA, recombinant proteins, antibody fragments, mRNA, vaccines and conjugates; complex and NGS oligonucleotides; peptide-oligo conjugates; custom RNA/DNA aptamers; reagents and kits, in compliance with local and international standards.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eurogentec company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Creative Peptides

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Creative Peptides

2.2 - Growth funds investing in similar companies to Creative Peptides

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Creative Peptides

4.2 - Public trading comparable groups for Creative Peptides

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Creative Peptides

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Creative Peptides

What does Creative Peptides do?

Creative Peptides is a provider of custom peptide synthesis and process development, specializing in bioactive peptides from small-scale research to large-scale clinical and commercial production. Offers peptide modifications (phosphorylation, glycosylation, lipidation), analysis, pharmaceutical peptide development support (formulation, regulatory compliance), GMP manufacturing for trials and commercial use, and catalog products, including protein glycosylation.

Who are Creative Peptides's competitors?

Creative Peptides's competitors and similar companies include Surepharm, ShangPharma Innovation, Catalyst Clinical Research, 3P Biopharmaceuticals, and Eurogentec.

Where is Creative Peptides headquartered?

Creative Peptides is headquartered in United States.

How many employees does Creative Peptides have?

Creative Peptides has 1,000 employees 🔒.

When was Creative Peptides founded?

Creative Peptides was founded in 2010 🔒.

What sector and industry vertical is Creative Peptides in?

Creative Peptides is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Creative Peptides

Who are the top strategic acquirers in Creative Peptides's sector and industry

Top strategic M&A buyers and acquirers in Creative Peptides's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Creative Peptides?

Top strategic M&A buyers groups and sectors for Creative Peptides include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Creative Peptides's sector and industry vertical

Which are the top PE firms investing in Creative Peptides's sector and industry vertical?

Top PE firms investing in Creative Peptides's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Creative Peptides's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Creative Peptides's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Creative Peptides's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Creative Peptides include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Creative Peptides's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Creative Peptides?

The key public trading comparables and valuation benchmarks for Creative Peptides include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Creative Peptides for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Creative Peptides with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Creative Peptides's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Creative Peptides with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Creative Peptides's' sector and industry vertical?

Access recent funding rounds and capital raises in Creative Peptides's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Creative Peptides

Launch login modal Launch register modal